IRadimed Corp. (IRMD)
84.59
-0.23
(-0.27%)
USD |
NASDAQ |
Oct 07, 10:44
IRadimed EPS Diluted (Quarterly) : 0.4054 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.4054 |
| March 31, 2026 | 0.4521 |
| December 31, 2025 | 0.5004 |
| September 30, 2025 | 0.4336 |
| June 30, 2025 | 0.4498 |
| March 31, 2025 | 0.3655 |
| December 31, 2024 | 0.4018 |
| September 30, 2024 | 0.3952 |
| June 30, 2024 | 0.3842 |
| March 31, 2024 | 0.3244 |
| December 31, 2023 | 0.3564 |
| September 30, 2023 | 0.3979 |
| June 30, 2023 | 0.3285 |
| March 31, 2023 | 0.2685 |
| December 31, 2022 | 0.2908 |
| September 30, 2022 | 0.2713 |
| June 30, 2022 | 0.2566 |
| March 31, 2022 | 0.1965 |
| December 31, 2021 | 0.3081 |
| September 30, 2021 | 0.2044 |
| June 30, 2021 | 0.1171 |
| March 31, 2021 | 0.1108 |
| December 31, 2020 | 0.0509 |
| September 30, 2020 | 0.086 |
| June 30, 2020 | -0.1749 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.1431 |
| December 31, 2019 | 0.2626 |
| September 30, 2019 | 0.1994 |
| June 30, 2019 | 0.1708 |
| March 31, 2019 | 0.1509 |
| December 31, 2018 | 0.1396 |
| September 30, 2018 | 0.1968 |
| June 30, 2018 | 0.11 |
| March 31, 2018 | 0.07 |
| December 31, 2017 | 0.02 |
| September 30, 2017 | 0.02 |
| June 30, 2017 | 0.03 |
| March 31, 2017 | -0.02 |
| December 31, 2016 | 0.10 |
| September 30, 2016 | 0.13 |
| June 30, 2016 | 0.19 |
| March 31, 2016 | 0.19 |
| December 31, 2015 | 0.19 |
| September 30, 2015 | 0.15 |
| June 30, 2015 | 0.15 |
| March 31, 2015 | 0.12 |
| December 31, 2014 | 0.02 |
| September 30, 2014 | 0.02 |
| June 30, 2014 | 0.11 |
| March 31, 2014 | 0.0503 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Accuray, Inc. | -0.0154 |
| Micron Solutions, Inc. | -- |
| IDEXX Laboratories, Inc. | 4.267 |
| Neogen Corp. | -0.0519 |
| Orthofix Medical, Inc. | -0.3862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 5.218M |
| Revenue (Quarterly) | 20.47M |
| Total Expenses (Quarterly) | 15.25M |
| Enterprise Value | 1.025B |
| Gross Profit Margin (Quarterly) | 74.07% |
| Profit Margin (Quarterly) | 25.50% |
| Earnings Yield | 2.12% |
| Operating Earnings Yield | 2.53% |
| Normalized Earnings Yield | 2.118 |